Abstract:Small fiber neuropathy (SFN) belongs to a heterogeneous group of disorders in which thinly myelinated Aδ and unmyelinated C-fibers are primarily affected, leading to neuropathic pain and autonomic symptoms. SFN can be associated with systemic conditions such as diabetes, autoimmune diseases, exposure to drugs and toxins, and infection, with the list of associated diseases continuing to expand. Variants in the SCN9A, SCN10A, and SCN11A genes encoding Nav 1.7, Nav 1.8, and Nav 1.9 sodium channel subunits, as well as in the TRPA1 gene, have been found in SFN patients, expanding the spectrum of underlying conditions and enhancing our understanding of pathophysiological mechanisms. There is also growing interest in immune-mediated forms that could help identify potentially treatable subgroups. According to international criteria, diagnosis is established through clinical examination, the assessment of intraepidermal nerve fiber density, and/or quantitative sensory testing. Autonomic functional tests allow for a better characterization of dysautonomia in SFN, which can be subclinical. Other tests can support the diagnosis. Currently, the management of SFN prioritizes treating the underlying condition, if identified, within a multidisciplinary approach that combines symptomatic pain therapy, lifestyle changes, and biopsychological interventions. Emerging insights from the molecular characterization of SFN channelopathies hold promise for improving diagnosis, potentially leading to the discovery of new drugs and refining trial designs in the future. This article reviews the clinical presentation, diagnostic workup, and advancing knowledge of associated conditions and interventional management of SFN. Article published online: 21 October 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Research Advances in Clinical Diagnosis and Treatment of Sensory Neuron Diseases

[Clinical and Neurophysiologic Profiles of Sensory Neuron Disease].

Analysis of the Clinical Features of 6 Patients with Sensory Neuronopathies

Sensory Neuronopathy Involves the Spinal Cord and Brachial Plexus: a Quantitative Study Employing Multiple-Echo Data Image Combination (MEDIC) and Turbo Inversion Recovery Magnitude (TIRM)

Sensory Neuronopathies: Clinical Presentation, Management, and Outcome

Sensory neurology: A new neurology subspecialty and opportunity

Research Progress in the Treatment of Sensorineural Olfactory Dysfunction

Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN)

Research progress on the treatment and nursing of sensorineural hearing loss

Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy

[Advances in the Research of Sensory Nerve Regeneration in Tissue Engineering Skin].

Sensory symptoms in Parkinson's disease: Clinical features, pathophysiology, and treatment

Sensory Nerve Disturbance in Amyotrophic Lateral Sclerosis

Progress in the treatment of diabetic peripheral neuropathy

Current Advances in Gene Therapies of Genetic Auditory Neuropathy Spectrum Disorder

Clinical advances in painful and painless diabetic neuropathy

Research Progress on the Detection of Diabetic Cardiovascular Autonomic Neuropathy

Mitochondrial Dysfunction and Therapeutic Targets in Auditory Neuropathy

The Evolving Landscape of Small Fiber Neuropathy

Diabetic Peripheral Neuropathy: Pathogenetic Mechanisms and Treatment

Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes